Skip to main content
Equibles

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in IMVT — Immunovant, Inc.

CIK 1705339 CAUSEWAY BAY, K3
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,780,670
+$997,134 QoQ
Shares Held
72,169
+0.5% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 226 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $446,316,962 across 286 Biotechnology names. IMVT ranks #40 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 150,692 $74,853,236
2 REGN
Regeneron Pharmaceuticals, Inc.
 59,595 $37,159,864
3 ALNY
Alnylam Pharmaceuticals, Inc.
 63,265 $19,044,662
4 RPRX
Royalty Pharma plc
 259,390 $14,543,997
5 TWST
Twist Bioscience Corp
 100,108 $10,299,110
6 INCY
Incyte Corp
 83,084 $9,418,401
7 PRAX
Praxis Precision Medicines, Inc.
 27,185 $9,101,265
8 MRNA
Moderna, Inc.
 106,564 $7,462,676

All Filings in IMVT

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,780,670 72,169
2026-03-31 $1,783,536 71,801
2025-12-31 $1,024,552 40,305
2025-09-30 $595,650 36,951
2025-06-30 $682,256 42,641
2025-03-31 $700,193 40,971
2024-12-31 $931,921 37,623
2024-09-30 $1,076,707 37,766
2024-06-30 $870,037 32,956